The mRNA expression of the proinflammatory cy tokine interleukin-l[3 (IL-I[3) has been shown to be induced in neural elements during ischemia. It is not clear which cells generate the IL-l[3 mRNA and eventually synthesize IL-l pro tein and which cells respond to this signaling by producing IL-l receptors during ischemia. To clarify this question, rats were subjected to global ischemia by bilateral carotid occlusion and hypotension for 20 minutes, followed by reperfusion for 2 hours (n = 7), 8 hours (n = 7), or 24 hours (n = 7). Cryostat sections were hybridized using antisense oligonucleotide probes (30 di�er). Multiple cell markers were used in immu nohistochemical staining to identify the cells expressing IL-I[3 and IL-I R protein. The sham animals (n = 5) showed no or only a weak expression of IL-I R or IL-I[3 mRNA. The number of IL-I[3 mRNA-expressing cells was significantly increased by 2 hours of reperfusion in several brain areas including cortex (l 2-fold compared with sham) and caudate-putamen (14-fold), and was maximally increased in most hippocampal regions by 8 hours of reperfusion (mean ± SD of positive cells/field versus
Expression of cytokines, a heterogeneous group of pleiotropic polypeptides mediating immune and inflam matory effects, can occur in the eNS as a response to local or systemic infection or injury. A number of cyto kines have been shown to be produced in ischemic brain injury, including interleukin-6 (IL-6), fibroblast growth factor, transforming growth factor-[3, interleukin 1-[3 (IL-I [3) (Hopkins and Rothwell, 1995) , and tumor ne crosis factor-a (Liu et aI., 1994; Szaflarski et a!., 1995) . lnterleukin-l is a potent enhancer of inflammatory reac tions through liberation of other inflammatory metabo lites or enzymes such as prostaglandins, collagenase, and phospolipase A2 (Benveniste, 1992) . Interleukin-l also stimulates numerous cell types to synthesize cytokines, including IL-6, tumor necrosis factor-a, colony stimulat ing factors, and lL-1 itself (Benveniste, 1992) .
Interleukin-I has been postulated to be a mediator in the pathogenesis of ischemic brain damage. It may par ticipate in the transformation of the vascular endothelium from normally anti-thrombotic to procoagulant and pro-adhesive surface after ischemia (Hallenbeck and Dutka, 1990) . Moreover, IL-l acts on endothelial cells to pro mote leukocyte adhesion and transmigration into the brain tissue, thus aggravating the ischemic brain damage and edema (Hallenbeck and Dutka, 1990) . In fact, intra cerebroventricular injection of recombinant human IL-l has been shown to increase brain edema in transient focal ischemia in rats, and this can be antagonized by injection of an IL-I blocker, zinc protoporhyrin (Yamasaki et aI., 1992) . A pa. thophysiologic role for IL-l in cerebral isch emia is further supported by several recent studies, where IL-l antagonism has been shown to protect against isch emic damage (Relton and Rothwell 1992; Betz et aI., 1995; Garcia et aI., 1995; Yamasaki et aI., 1995) . On the other hand, wound healing and neuronal growth and re pair have been suggested to be mediated by this multi faceted cytokine (Rothwell, 199 1) .
Cytokines initiate their actions by binding to specific membrane receptors on target cells. The response of a particular cell to a given cytokine is determined by the level of expression of the cytokine receptors and the signal transduction pathways of the target cell, which are activated by the cytokine (Benveniste, 1992) . The IL-l effect is mediated by two distinct gene products, namely IL-la and IL-II3. Both IL-l forms recognize the same cell surface IL-l receptor, IL-IR (Hopkins and Rothwell, f 1995 ). An endogenous IL-l inhibitor, interleukin-l receptor antagonist (IL-IRa), mRNA has been described in the hippocampus, hypothalamus, choroid plexus, cer ebellum, and in the blood vessels throughout the un stimulated rat brain (Licinio et aI., 199 1) . Later, the mRNA for the type I IL-l receptor was shown to colo calize with the above-mentioned distribution of the en dogenous antagonist of IL-1 function (Cunningham et aI., 1992) .
Although neurons, astroglia, perivascular monocytes/ macrophages, and endothelial cells are also capable of expressing cytokines, the dominant source of cytokines after brain damage seems to be activated microglia (Hop kins and Rothwell, 1995) . However, the cellular local ization of IL-l receptors(s) in the brain is not known, neither is any description of the receptor in brain isch emia available. Therefore, we studied the temporal and spatial distribution of mRNA for IL-113 and IL-IR com bined with the topography of IL-113 and IL-IR protein distribution in a rat transient global ischemia model. We hypothesized that global ischemic injury would result in differential expression of interleukin-l and its receptor in glial and neuronal cells, enabling us to better characterize the relationship between these neural elements through cytokines in cerebral ischemia.
MATERIALS AND METHODS
Twenty-six, 16-week old (275 to 470 g; mean 358 ± 53.0 g) male Sprague-Dawley rats (Taconic Farms, Germantown, NY, J Cereb Blood Flow Metah, Vol. 17, No. 10, 1997 U.S.A.) were used. The experiments reported herein were con ducted according to the principles set forth in the Guide fo r Care and Use of Laboratory Animals, Institute of Laboratory Animal Resources, National Research Council (DHEW publi cation No. NIH 85-23, 1985) .
Global ischemia
Transient forebrain ischemia was produced as previ ously described by Smith et al. (1984) . In brief, ischemia was achieved in rats by bilateral carotid artery clamping for 20 minutes combined with hypotension induced by systemic hemorrhage and followed by 2, 8, or 24 hours of reperfusion. Rats were anesthetized with J to 2% halo thane and 30/70 mixture of O2 and N20. The CBF was measured on-line (2-mm posterior to bregma) by laser Doppler flowmetry (BPM, 403, TSI Inc., St. Paul, MA, U.S.A.) according to a technique described elsewhere (Lindsberg et aI., 1991) . The volume of blood withdrawn through a PE-50 catheter placed in the left femoral artery varied between 6.0 to 12.0 mL and was adjusted to main tain CBF values below 10% of the baseline value. Blood gas analyses were performed repeatedly to nearly half of the animals. The pH was corrected routinely by giving sodium bicarbonate (75 mg/mL) intravenously. Mean ar terial blood pressure was recorded in all experimental animals (Physiograph MK IV, Narco, Houston, TX, U.S.A.). Five sham animals went through the same sur gical procedures except for the occlusion of the carotid arteries and the systemic hypotension. The animals were killed with an overdose of pentobarbital at 2 (n = 7), 8 (n = 7), or 24 hours (n = 7) of reperfusion. Transcardial perfusion with precooled phosphate buffered saline (PBS) for 4 to 5 minutes was completed before the re moval of the brain, which was immediately frozen and stored at -70°C until examined. The sham animals were killed at 24 hours of reperfusion.
Tissue preparation
Coronal sections (18 f,Lm) of the frontal lobe at the level of the striatum and the hippocampus were cut in a cryostat (Model Microm 505HM, Microm GMBH). Two sections were mounted on a gelatin-coated slide (Rite-on micro slide, Becton Dickinson Labware, NJ, U.S.A.) separated by about 360 f,Lm.
In situ hybridization of brain sections
The probes used were 30 base pair oligonucleotide se quences complementary to the rat cDNA to mRNA sequences for rat IL-I 13 and IL-I receptor (Type I) in the GenBank. The antisense oligonucleotide sequences were as follows: (1) IL-113: TGT GCC ACG GTT TTC TTA TGG CTC TGA GAG and (2) IL-I receptor: GTG TCC AGC ACA GGA TCC AGG GTT AAT AAG. These sequences had no overlap with other rodent cytokine mRNA and they had less than 10 base pair continuous homology to any other mRNA sequences in the rodent gene bank. Northern blot analysis of the target RNA for each oligonucleotide sequence demonstrated upregulation by lipopolysaccharide treatment and the positive blots corre sponded in size to the appropriate mRN A for IL-I j3 and IL-I receptor as described in the literature. Sense probes of equiva-lent length contained a mirror image sequence of the antisense oligonucleotides.
The tissue sections were postfixed in 4% formaldehyde in PBS (phosphate buffered saline) for 10 minutes and washed quickly with PBS. Pretreatment of the slides was continued with further fixation in 4% formaldehydelPBS, followed by two PBS rinses. The sections were then acetylated for 10 min utes with 0.25% (volume to volume ratio) acetic anhydride and 0.1 mollL triethanolamine in sterile 0.9% (weight to volume ratio) NaCl (pH 8.0), dehydrated through graded ethanols, ex tracted with chloroform for 5 minutes and rehydrated through graded ethanol" s. The oligonucleotides were 3 ' -end labeled with e S S]dATP using terminal deoxytransferase to a specific activ ity of approximately 5 x 10 6 cpmJng. Light microscopy of in situ hybridization slides The Nissl-stained glial cells were identified based on their small size (less than 10 to 15 fLm) and intensive staining ("dark cells") (Gerfen, 1989) . The cells were counted as positive when they showed >20 silver grains per cell with the magni fication of 256x (Fig. I) . The mean of positive cells per field was based on counting 2 or 5 fieldslbrain area in each animal with the magnification 400x (Tables I, 2, and 3).
Immunohistochemistry
The slides were postfixed for 30 minutes in 4% formalde hyde/PBS and rinsed quickly with PBS. To enhance the pen etration of the antibodies, the slides were incubated in .3% 
Western blotting
The specificity of the IL-I(3 antibody was tested by Western blotting ( 
Statistical analysis
The statistical significance of the differences between the means of the groups was estimated by one-way analysis of variance followed by Dunnet's post hoc test. A P value less than .05 was considered statistically significant.
RESULTS

Validation of the ischemic insult
Careful on-line monitoring of the CBF of the experi mental animals at the baseline, during global ischemia, and 5 minutes after reperfusion verified equal ischemic/ reperfusion insult in all experimental groups (percent- 38.S ± 21.7* 48.8 ± 37.1 * 46.3 ± 36.S* 8 h (n = 7)
3S. 1 ± 20.1 * 40.6 ± 29.1 31.2 ± 25.8 24 h (n = 7)
22.0 ± 12.9 17.9 ± IS.5 IS.4 ± 11.S
The upregulation of interIeukin-lf3 (lL-1(3) mRNA at the level of the striatum after tran&ient global ischemia. The estimation is based on light microscopic evaluation of the intensity of the mRN A signal (400x). The data represent mean ± SD of positive cells/field based on counting 2 (CA2 region) or 5 fields (other areas) per respective brain area in the sham group, and after 2, 8, and 24 hours of reperfusion (n = 26 in the striatum).
* p < 0.05 determined by one-way analysis of variance and Dunnet's post hoc test.
ages of the baseline CBF value [100%] being 3. 6 ± 1.3; 5. 1 ± 2.5; 5.4 ± 2.6 during ischemia, and 154.4 ± 48. 1; 170.3 ± 37.3; 177.8 ± 37.7 after 5 minutes of reperfusion in the groups of 2, 8, and 24 hours of reperfusion). No significant differences between the groups existed either at the baseline, during ischemia, or after 5 minutes of reperfusion (determined by analysis of variance). The mean arterial blood pressure (mean arterial blood pres sure ± SD) of the experimental animals was 111 ± 15.8 mm Hg, 56.2 ±1'22. 1 mm Hg, and 135.4 ± 18.4 mm Hg at the baseline, during ischemia, and after 5 minutes of reperfusion, respectively. As expected, the animals were mildly acidotic after the ischemic/hemorrhagic period. On the average, the blood pH dropped to 7.32 ± 0.08 similarly in all groups (7.31 ± 0.05, 7.33 ± 0.09, 7.37 ± 0'()6 in the 2-, 8-, and 24-hour groups, respectively). Because the rats remained on spontaneous respiration, they were mildly hypercarbic (peo2: 46.75 ± 7.97) during the anesthesia, but the oxygen tension was maintained above 139 mm Hg in each animal.
Specificity of the ill situ oligonucleotide probes
The design and the Northern blot analysis of the target DNA of the probes is described in the Materials and Methods. According to the protocol described above, an independent second labeling and hybridization of the probes were performed to ascertain the reproducibility of the in situ hybridization results. At the level of the stria tum, a second hybridization (n = 16) of IL-l rp and IL-I receptors was repeated in brain sections adjacent to the first hybridization (n = 26). At the level of the hippo campus, four animals from each group were used for both hybridizations (n = 16). The distribution of the mRNA signal was estimated by a blinded investigator. The reproducibility for IL-113 mRNA was 75%/87.5%, and for IL-l receptor mRNA 58.3%/87.5% at the level of the striatum and the hippocampus, respectively (overall reproducibility 77. 1 %). RNAse pretreatment of the sec tions yielded reduction or abolition of the mRNA signal. The sense probes did not show any hybridization over low background signal (data not shown).
Specificity of immunohistochemistry
Omitting the primary or secondary antibody in the avidin-biotin-method resulted in immunoreactivity com parable to the background. Omitting the AB-complex resulted in total loss of staining. The nonspecific immu noglobulins of the same (sub )class as the antibodies of interest (IL-II3, IL-l R, and cell markers) revealed non specific staining (data not shown). The IL-1 RI antibody staining was abolished by preadsorption with accompa nying control peptide (Cat No. sc-689P, Santa Cruz Bio technology, Inc.) in lOx (weight) excess ( Fig. 3A and B ). Western blot detection of rat recombinant IL-ll3 (Cat No. 50 1 -RL, R&D Systems Inc.) was run parallel with the polyclonal antibody used for the immunohistochemical staining (Cat No. 124, Cytokine Sciences, Inc.) and with a polyclonal antibody later available from Endogen (Cat No. PR-427B) plus a polyclonal antibody (Cat No. AF-501-NA, R&D Systems). All antibodies detected a band of simi lar size corresponding to rat recombinant IL-I I3 in a semiquantitative manner as determined by densitome try of the autoradiograms (Fig. 2 ). Control incubation of parallel filter with normal rabbit serum did not detect the The upregulation of interleukin-I f3 (IL-I f3) mRNA at the level of the hippocampus after transient global ischemia. The estimation is based on light microscopic evaluation of the intensity of the mRNA signal (400x). The data represent mean ± SD of positive cells/field based on counting 2 (CA2) or 5 fields (other areas) per respective brain area in the sham group, and after 2, 8, and 24 hours of reperfusion (n = 16 in the hippocampus). CA I, CA I region of the hippocampal formation; CA2, CA2 region; CA3/4, CA3 and CA4 regions; DG, dentate gyrus.
* p < 0.05 determined by one-way analysis of variance and Dunner's post hoc test. ** p < 0.0 1 determined by one-way analysis of variance and Dunner's post hoc test. The numbers represent the mean ± SO of IL-I receptor (IL-IR) mRNA expressing cells/field and was determined by counting two (CA2) At the level of striatum (caudate-putamen), no or only a weak white matter signal for IL-I [3 mRNA or a low cortical expression combined with low caudate-putamen expression was seen in the sham animals (Table I; (Table 2) .
At the level of the striatum, no or only a low IL-IR mRNA expression was found in the sham animals ( . At the level of hippocampus, low IL-l R mRNA expression was detected in the sham animals in the CAl through CA3/CA4 regions, and/or dentate gyrus (Table  3 ; Fig. IE) . A constitutive expression of IL-I [3 and IL-IR over microvascular structures and a weak mRNA signal in the meninges and choroid plexus was detected in sham ani mals.
Ischemia-induced changes in IL-ll3 and IL-l receptor (IL-IR) mRNA A maximal increase in the number of IL-I[3 mRNA positive cells was detected already by 2 hours of reper fusion in the forebrain areas including cortex (12-fold increase), caudate-putamen (l4-fold), and white matter areas (a 5-fold increase in corpus callosum; Table 1) . A submaximal to maximal increase in IL-I [3 mRNA was also seen at the level of hippocampus in the CAl region (9-fold) and dentate gyrus (4-fold; Table 2) reperfusion. In the CA2 and CA3/CA4 regions of the hippocampus, the maximal increase was reached by 8 hours of reperfusion (a 10 and 14-fold increase, respec tively; Table 2 ). Correspondingly, maximal increase in the number of IL-I R mRNA-positive cells was evident in the CAl region (l6-fold) and dentate gyrus (24-fold) by 2 hours of reperfusion, while the maximal intensifi cation in the receptor mRNA was detected by 8 hours of reperfusion in the CA2 and CA3/CA4 regions of the hippocampus (Table 3) . After 8 hours of reperfusion, IL-I[3 signal remained induced in the cortex (Fig. lB) , caudate-putamen, and white matter areas (Table 1) . Also IL-I R mRNA expres sion was evident in these areas (Fig. ID) . At the hippo campal level, CA I , CA2, and CA3/CA4 regions showed maximally induced IL-l[3 mRNA, while the expression in dentate gyrus was comparable to 2 hours of reperfu sion (Table 2) . Likewise, the mRNA signal for the re ceptor was induced in CAl ( Fig. IF) through CA3/CA4 areas but started attenuating in the dentate gyrus (Table  3 ). The cortical upregulation of IL-IR in neurons en compassed all cortical layers or was focused to layers II to IV.
After 24 hours of reperfusion, expression of IL-I[3 mRNA started attenuating in the white matter areas, cau date-putame \J , and cortex (Table I ). The CAl region of the hippocampus remained especially strongly induced for IL-l[3, while the mRNA expression in the CA2 to CA3/CA4 regions and dentate gyrus was reduced more drastically (Table 2 ). In accordance, IL-I R mRNA signal remained highly induced exclusively in hippocampal CA I region but dropped to moderate levels in other hip pocampal areas (Table 3) , and even less striking induc tion was still seen in the cortex, corpus callosum, and caudate-putamen (data not shown).
The upregulated cortical signal for both IL-I [3 and IL-IR was predominantly neuronal at all time points af ter ischemiaireperfusion ( Fig. IB and D) . The striatal expression for IL-l[3 and IL-I R showed no clear pre dominance for neuronal cells at any reperfusion times. Only a weak mRNA signal for IL-I[3 and IL-I R was detected in the meninges, microvascular structures or in the choroid plexus of either the sham-operated or post ischemic animals. No upregulation by ischemial reperfusion could be detected in these structures.
IL-ll3 protein expression in sham animals
Low or moderate IL-I[3 immunoreactivity was evident in all sham animals. IL-I [3 immunoreactivity was shown at the level of the striatum, corpus callosum, cortex, and caudate-putamen (Table 4) . At the hippocampal level, CA 1 through CA3/CA4 and dentate gyrus were IL-I[3 positive (Table 5 ) along with white matter areas and septal, deep brain areas.
Ischemia-induced changes in the IL-ll3 protein expression
After 2 hours of reperfusion, the number of IL-I[3positive cells tended to increase in the corpus callosum, cortex, and caudate-putamen (Table 4 ). Similar tendency of IL-J [3 immunoreactivity was also seen in the hippo campal formation confined to cells consistent with glial morphology (Table 5 ; see text below).
By 8 hours of reperfusion, IL-I f3 immunoreactivity tended to be intensified in striatal and hippocampal re gions (Tables 4 and 5 ). The IL-I[3 immunoreactive cells sharing the morphology with glial fibrillary acidic pro tein-positive cells were hypertrophied, had swollen cell somas, and shorter, thicker, and waiver processes than the IL-l [3 immunoreactivity cells in sham animals. This morphologic change was still evident at 24 hours of Interleukin-Ij3 protein expression. The numbers represent the animals in groups of low, moderate, or strong immunoreactivity. The low expression corresponds to a mean of 0 to 10 immunoreactive cells/field in corpus callosum and to 0 to I positive cells/field in cortex and caudate putamen. Similarly, the moderate protein expression corresponds to a mean of II to 22 and 2 to 3 positive cells/field and strong protein expression to >2 3 and >4 positive cells in corpus callosum and cortex/striatum, respectively. The mean of immunoreactive cells is based on counting 5 fields per animal (500x; n = 25) in either the white matter (corpus callosum) or gray matter areas (cortex/striatum). The mean number ± SD of IL-I i3 immunoreactive cells with glial morphology in the hippocampal regions. The numbers represent the mean ± SD of immunoreactive glial cells/field and was determined by counting 2 (CA2) or 5 fields (other areas) per brain area in sham and post-ischemic animals (n = 16) under light microscope (500x). Note the difference to the mean numbers given in Table 2 which reperfusion and corresponded to increased glial fibrillary acidic protein immunoreactivity ( Fig. 4A and B) . The amount of IL-I rp-expressing cells tended to be increased still by 24 hours of ischemiaireperfusion at the striatal level and reached significance in hippocampal regions CA2 and dentate gyrus, while in the CA I and CA3/CA4 regions the number of immunoreactive cells started attenuating (Tables 4 and 5) . The main cell type expressing induced IL-l rp immunoreactivity after ischemia/different reperfusion periods was identical to glial fibrillary acidic protein-positive astrocytes observed in the adjacent section (Fig. 4B) . Thin processes staining with IL-l rp were also indistin guishable from MAB328-positive (for myelin/ oligodendrocytes) cell processes (Fig. 4C) . Staining with the OX-42 antibody for granulocytes, macrophages, and microglia revealed coexpression with IL-l rp in perivas cular macrophages. Although microglial activation was evident with the OX-42 staining and was seen to expand from the white matter areas to the cortex by 24 hours of reperfusion, only sporadic IL-l rp-positive cells were identical with OX-42 positive microglial cells ( Fig. 4E  and F) . Sporadic IL-I rp positive perivascular cells were also identified by ED2 staining. lnterleukin-l rp immuno reactivity was not seen in structures that stained with the cell markers for neuronal cell bodies and dendrites (mi crotubule-associated protein-2) or for endothelial cells (von Willebrand factor) (data not shown).
IL·IR protein expression in sham animals
Interleukin-lR immunoreactivity was detected in the sham brains (n = 4; Table 3 ). The widespread expres sion localized in the cytoplasm of neurons throughout the cortex, superior colliculus, medial geniculate, central gray, ventral tegmental area, substantia nigra, and the dentate gyrus and hippocampal CAl, CA2, and CA3/4 regions. Non-neuronal immunoreactivity could not be confirmed by identical cell morphology with any of the cell markers used, which however does not exclude glial origin of some of the IL-lR-positive small cell somas (Fig. 3A) . Additionally, IL-I R immunoreactivity was de tected in corpus callosum, possibly in oligodendrocytes. A weak constitutive IL-I R immunoreactivity was also detected over microvascular endothelium. The choroid plexus/ependymal cells were comparable to rabbit IgO or preadsorption controls (data not shown).
Ischemia·induced changes in the IL·IR protein expression
In the postischemic brains (n = 12), IL-l R protein expression was detected in cortex (Fig. 3A) , dentate gy rus, and CA2 to CA3/CA4 regions of the hippocampal formation (Table 3) . While no increase in the number of receptor positive neurons could be detected after isch emia, the proportion of neuronal cell somas positive for IL-l receptor was determined by counting immunoreac tive cells from slides counter stained with hematoxylin. The percentage of neurons immunoreactive for IL-l re ceptor in the CAl region of the hippocampus in the sham animals (91 %; n = 4) was found to be identical to the percentage 8 hours after ischemia (91 %; n = 4). Simi larly, in the dentate gyrus the sham and postischemic proportions of the receptor protein positive neurons were 94% and 95%, respectively. However, the intensity of immunostaining was increased in most cases by isch emia/reperfusion in the cells capable of protein transla tion (Fig. 3D) . By 24 hours of reperfusion in three out of four animals investigated, the number of IL-IR immu noreactive neurons was decreased creating a 'patchy' immunoreactivity pattern in the CAl region (Fig. 3E) . Additionally, IL-IR immunoreactivity was evident in sporadic endothelial structures, corresponding with the mRNA expression ( Fig. 3F and 0) . No other structures, except these aforementioned areas containing selectively vulnerable neurons, were systematically evaluated after ischemia/reperfusion. An equally weak IL-IR immuno- staining for IL-1 i3 protein in the CA1 region of the hippocampus after 24 hours of reperfusion. Note the multiform cell types showing IL-1 i3 immunoreactivity, which corresponds to glial cell morphology as shown in stainings with glial cell markers (Fig. 4B, C, and E) . Also, noteworthy is the total absence of neuronal IL-1 i3 staining in the granular cell layer of the CA 1 region shown to the left on the photomicrograph (open arrow) (256x). (8) A photomicrograph showing glial fibrillary acidic protein-positive astrocytes in the CA1 region of the hippocampus after 24 hours of reperfusion. Hypertrophy and swelling of the cell somas together with shortened, thickened cell processes is evident (256x). (C) A photomicrograph showing MAB328 immunoreactivity representing oligodendrocytes and their pro cesses in the CA1 region of the hippocampus after 24 hours of reperfusion (256x). (0) A photomicrograph showing IL-1R immunore activity in the CA 1 region of the hippocampus after 24 hours of reperfusion. Immunoreactivity of the granular cell layer neuronal somas is evident and no glial immunoreactivity is seen (note no counter stain) (500x). (E) A photomicrograph showing OX-42 staining in the corpus callosum at 24 hours of reperfusion. The hypertrophied morphology of the microglial cells shares identity only with sporadic IL-1 i3 immunoreactivity cells as shown in Fig. 4F (black arrow) . (400x). (F) IL-1 i3 immunoreactivity in the corpus callosum at 24 hours of reperfusion. The pattern of the IL-1 i3-positive cells suggests either oligodendrocytic or astrocytic origin of the immunoreactivity (arrows) together with a hypertrophied pattern fitting with microglial IL-1 i3 protein expression (black arrow). (256x). The black bar represents 40 nm.
reactivity was detected both in the sham and postisch emic corpus callosum, possibly caused by oligodendro cytic expression of the receptor (data not shown).
DISCUSSION
Global cerebral ischemialreperfusion acutely altered the expression of IL-l rp and its receptor in a number of ischemia-sensitive brain structures, such as the hippo campal pyramidal cell layers, granular cell layers of the dentate gyrus, cortex, and striatum. While IL-I rp mRNA expression was increased both in the white matter areas and in the aforementioned gray matter structures, a co inciding increase in IL-I R gene expression was seen ex clusively over neuronal cell bodies of the hippocampus. In contrast to the strong expression of IL-I R in hippo campal neurons, there was weak expression of the IL-l R mRNA and only a weak noninducible staining for the IL-I R protein in the white matter areas, suggesting that ischemialreperfusion induces IL-I R protein primarily in neuronal cell bodies. At the protein level, a tendency for increased glial IL-I rp was evident, while no neuronal IL-l rp protein could be detected. An interesting scenario develops in which glial is incited to propagate IL-l rp effects in postischemic brain (lL-l rp expression in glia), the targets being q:he neurons (neuronal expression of IL-lR).
Several previous studies have reported induced IL-I rp gene expression in brain ischemia (Minami et aI., 1992; Liu et aI., 1993; Yabuuchi et aI., 1994; Wang et aI., 1994; Szaflarski et aI., 1995) . In agreement with our present results, global ischemia induced IL-I rp mRNA in the cortex and striatum 4 hours after reperfusion and the signal decreased toward sham level at 24 hours (Minami et aI., 1992) . In contrast to our findings, no mRNA ex pression was seen in the striatum before the third day of reperfusion in a transient ischemia model (4 vessel oc clusion for 30 minutes) (Wiessner et aI., 1993) . The hip pocampal formation remained negative throughout the 15 minute-7 day observation period (Wiessner et aI., 1993) . However, other studies have clearly shown an early induction of IL-I rp mRNA in the hippocampus (Minami et aI., 1992; Yabuuchi et aI., 1994; Szaflarski et aI., 1995) and this was also confirmed in the present study. Yabuuchi et al. (1994) observed similar topogra phy of IL-I rp mRNA upregulation in the postischemic cortex as seen in our study, and an early non neuronal activation in the polymorphic layer of the hippocampus 30 minutes after ischemia that could precede the later (2 hours to 24 hours) neuronal mRNA expression seen in our study (Yabuuchi et aI., 1994) . In nonischemic rat brain, a predominantly neuronal signal patterns for IL-I rp mRNA was detected over the granule cell layer of the dentate gyrus and the CA 1 pyramidal cells of the hippo campus, over the granule cells of the cerebellum, the granule and peri glomerular cells of the olfactory bulb, and over dispersed cells of the ventromedial hypothala mus and frontal cortex (Bandtlow et aI., 1990) .
The distribution of IL-l receptors in the murine brain has been examined indirectly by binding assays of ra dioactively labeled IL-l by several investigators (Farrar et aI., 1987; Katsuura et aI., 1988; Takao et aI., 1990; Haour et aI., 1990; Ban et aI., 1991) and support our finding of IL-l receptor being expressed by neurons. Although only sporadic sham animals showed IL-lR mRNA expression in our study, the previously described gene expression of IL-IR (Type I) by in situ hybridiza tion (Cunningham et aI., 1992) was found in same areas as seen in our few IL-I R-positive sham animals. Fur thermore, we have now shown the IL-l R protein expres sion to be neuronal and widely distributed also in the postischemic rat brain.
In the present study, no neuronal IL-l rp protein ex pression could be detected either in the sham or post ischemic cortex, hippocampus or caudate/putamen. This is in agreement with previous studies that show neuronal IL-I rp immunoreactivity in the human and nonprimate brain is restricted to brain regions involved in endocrine and autonomic functions (Breder et aI., 1988; Lechan et aI., 1990) . Although the dilution of the polyclonal anti body used in our study (1: 100) resulted in a moderate level of background staining, which could impair the detection of faint immunoreactivity in the neuronal pro cesses, the parenchymal immunoreactivity had distinct glial morphology. However, induction of mRNA for IL l rp occurred in cortical and hippocampal neurons after ischemialreperfusion. Transcription of IL-J gene without translation is also induced by complement or calcium ionophore in peripheral blood mononuclear cells (Schin dler et a!., 1990a; Dinarello, 1991) . Activation of periph eral blood mononuclear cells by surface adherence in duces expression of IL-l rp mRNA but not the protein (Schindler et ai, I 990h) . Under this condition the cells are primed to respond with an exaggerated release of IL-l by subsequent stimulation with lipopolysaccharide (Schindler et aI., 1990b) . Our results show that in cortical and hippocampal pyramidal cells, ischemia induces ex pression of IL-l rp mRNA that is not translated into pro tein, thus possibly leaving the neurons in a "primed" state. In this preconditioned state even a modest stimu lation might result in a massive release of IL-I that could magnify the effect of glial IL-I and contribute to the delayed neuronal damage in these neurons. The pro longed mRNA expression (24 hours of reperfusion) of IL-l rp and even more notably the IL-I R seen in the cor tex, CA I region, and the dentate gyrus could further contribute to the delayed neuronal death described in these selective areas (Kirino, 1982) . Interestingly, in the present study, decreased IL-l R immunoreactivity was seen in hippocampal CAl and CA3 regions in a majority .I Cereb Blood Flow Melab, Vo/. 17, No. JO, 1997 of the animals after 24 hours of reperfusion, fitting with the evolution of delayed neuronal death. There was no correlation between the clearly upregulated IL-l R mRNA expression and translation into protein in these areas already after 2 and 8 hours of reperfusion (Table 3) . This could partly be caused by downregulation of IL-l receptor by IL-I, as has been described for murine Th2 cells (Dinarello, 1991) . This downregulation is suggested not to be a function of receptor occupancy, because it is observed at . IL-l concentrations that occupy less than 10% of the receptors. The mechanism is a decrease in the half-life of the mRNA for IL-IR (Dinarello, 199 1) . This Gould be applicable for not increased IL-l R protein seen in our study despite the robust upregulation of IL-l R mRNA. Furthermore, low receptor occupancy is sug gested to be enough to trigger intracellular signaling by IL-I in T cells and thus favors the idea of less pro nounced receptor protein expression to be effective (Di narello, 1991) .
Global ischemia induced upregulation of copper-zinc superoxide dis mutase mRNA whereas the protein ex pression was decreased in the gerbil hippocampus (Mat suyama et aI., 1993) indicating that the dissociation be tween mRNA and protein expression after ischemia is not restricted to the cytokine system. On the other hand, the discrepallcy between the IL-I � mRNA and protein expression in neurons might be caused by inhibition of IL-l synthesis in ischemic tissue. In a compromised en ergy state, the neurons could be able to transcribe mRNA for IL-I�, but lack the capability of translating the actual protein because of reduced overall protein synthesis. This reduction is suggested to be transient in cells that recover from the insult, but sustained in the cells destined to die (Siesjo et aI., 1995) . Indeed, our results indicated robust IL-I receptor message induction that did not translate into increased protein synthesis. However, a generalized inhibition of neuronal protein synthesis seems unlikely as the IL-IR protein was expressed in hippocampal neurons also in the postischemic brain and the percentage of positive cells remained unchanged. Moreover, the intensity of the staining tended to be in creased in the neurons capable of translation (Fig. 3D) .
IL-I � protein was almost exclusively expressed in glial cells, primarily in astrocytes and to a lesser degree in oligodendrocytes and microglia. Weak to moderate IL-I � immunoreactivity was occasionally detected in perivascular macrophages and monocytes. No immuno staining for IL-l � protein could be detected in neurons, although IL-l � mRNA colocalized with large neuronal cell bodies in the postischemic brain, showing differen tial expression of IL-I and its receptor by glia and neu rons after ischemiaJreperfusion. This emphasizes the role of neurons as targets of IL-J actions and lends support to our hypothesis, that glial IL-J � acting on neuronal IL-J R participates in the cytokine "cross-talk" between neural J Cereb Blood Flow Metab, Vol. 17, No. 10, 1997 elements at risk of metabolic damage. The postischemic induction of glial IL-J protein was consistent in all brain regions investigated and tended to correlate with the up regulated mRNA production (Tables 1, 2, and 3) . How ever, it may be that the increase in the number of TL-J� protein-positive cells is not the only factor that deter mines the biological efficacy of IL-I. Changes in the availability of IL-I could be reflected in the intensity of the immunostaining, which in tum is difficult to quanti tate and thus makes such an evaluation arbitrary. Indeed, a recent study using EIA-technique for IL-J � quantita tion showed the levels of TL-I to be significantly in creased in cortex, striatum, and hippocampus as opposed to other areas investigated after transient global ischemia in a gerbil brain (Saito et aI., 1996) .
Glial IL-I � protein expression was paralleled by neu ronal IL-IR synthesis, suggesting that neurons may be target cells for TL-l � effects in brain ischemia. Because both neuronal death and exitotoxic damage was reported to be inhibited by intracerebroventricular injection of IL IRa in the rat PMCAO model, binding of IL-I � on the IL-IR may have a pathophysiological role in ischemic brain (Relton and Rothwell, 1992) . Reduction in infarct size (64%) was achieved by adenoviral vector transfer of IL-IRa intracerebroventricularly 5 days before PMCAO in a rat (Betz et aI., 1995) . Although blocking of the possible IL-I binding sites of the ependymal cells (as suggested by binding of IL-I to choroid plexus; Farrar et aI., 1987) by IL-I Ra may contribute to the improved outcome in the above cited studies, the protective effect most likely is caused by blockade of the intraparenchy mal receptor(s). No ependymal immunoreactivity for type I IL-IR was seen in our study. On the other hand, the IL-I effects in brain ischemia may partly be mediated by leukocyte response as suggested by favorable results of leukocyte inhibition by systemically given IL-IRa in a PMCAO model (Garcia et aI., 1995) . Besides better neurological function and less weight loss, fewer leuko cytes were detected in the ischemic hemispheres of the treated animals along with fewer necrotic neurons and smaller area of pallor (Garcia et aI., 1995) . A direct effect of IL-l � on brain endothelium is supported by the pre sent findings that IL-l �-positive cells were found in close proximity to the parenchymal microvessels. Astro cyte end feet are in direct contact with endothelial cells and comprise an important part of the blood-brain bar rier. Interleukin-l � immunoreactivity was expressed in astrocytic processes surrounding intraparenchymal blood vessels and in perivascular macrophages. Although IL l � mRNA was sporadically seen over the endothelium of intraparenchymal blood vessels, IL-I � immunoreac tivity did not clearly colocalize with the endothelial cells. Endothelial cells are capable of TL-J expression but the principal product in these cells is IL-la (Dinarello, 1991) which our IL-l � selective antibody may not be able to detect. However, a weak constitutive expression of IL-l receptor mRNA and protein was present in the brain microvascular endothelium. The presence of IL-IR in the endothelial cells and the IL-l � gene product in the sur rounding perivascular astrocytes and macrophages en able IL-l � contribute to the ischemic damage by directly activating endothelial cells to release arachidonic acid metabolites, platelet-activating factor, inducing endothe lial expression of adhesion molecules for leukocytes and platelets and' ultimately provoking the endothelium to undergo a change to a prothrombotic and proadherent surface (Hallenbeck, 1994) .
In summary, the present study showed upregulation of IL-l � mRNA and its receptor gene expression after global ischemia. Interleukin-l f3 and IL-I R mRNA up regulation took place in neuronal cell bodies in the post ischemic cortex and CAl through CA3/CA4 regions and the dentate gyrus of the hippocampal formation. A tran sient upregulation for IL-I f3 mRNA in the white matter areas was also detected. Differential protein expression was seen for the IL-l � and IL-I R, the former being expressed by glial cells (mostly astrocytes), the latter being localized in the neurons and, to a lesser degree in the endothelial cells, suggesting that neurons and endo thelium may be the primary targets of IL-l � in brain ischemia/repeFfusion injury.
